High-stakes heterogeneity in COVID-19
Editorial, Lancet Rheumatology, October 2020
Editorial, Lancet Rheumatology, October 2020
One size rarely fits all. An insufficient understanding of patient heterogeneity for COVID-19 is a high-stakes endeavour. Such understanding could help clinicians to treat patients earlier and with the most effective therapies, potentially making the difference between life and death.
Ethnic differences in COVID-19 infection, hospitalisation, and mortality: an OpenSAFELY analysis of 17 million adults in England
R Mathur et al, MEDRXIV, September 23, 2020
R Mathur et al, MEDRXIV, September 23, 2020
Putting (Big) Data in Action: Saving Lives with Countrywide Population Movement Monitoring Using Mobile Devices during the COVID-19 Crisis
MK Szocska et al, MEDRXIV, September 23, 2020
MK Szocska et al, MEDRXIV, September 23, 2020
Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area
SW Long et al, MEDRXIV, September 23, 2020
SW Long et al, MEDRXIV, September 23, 2020
No hay comentarios:
Publicar un comentario